,使VEGFR-2?

Nafiye Yilmaz1, Pinar Gulsen Coban2, Saynur Yilmaz2

  • 1Department of Reproductive Endocrinology, Zekai Tahir Burak Women's Health Education and Research Hospital, University of Health Sciences, Ankara, Turkey.

概括

在卵巢过度刺激综合征 (OHSS) 鼠标模型中,卡伯戈林治疗逆转了体重增加和卵巢扩大. 然而,它可能会影响子宫内膜血管内皮生长因子受体-2 (VEGFR-2) 的表达,这可能会影响试管婴儿的成功.